CMTM2

Chr 16

CKLF like MARVEL transmembrane domain containing 2

Also known as: CKLFSF2

The protein encoded by this gene belongs to the chemokine-like factor superfamily and may function in testicular development. Loss-of-function mutations in CMTM2 have not been established as a cause of human disease, though gain-of-function has been predicted as a potential disease mechanism. The gene shows high tolerance to loss-of-function variation in the general population.

Summary from RefSeq, Mechanism
0
Active trials
2
Pubs (1 yr)
26
P/LP submissions
0%
P/LP missense
1.70
LOEUF
GOF
Mechanism· predicted
Clinical SummaryCMTM2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
25 unique Pathogenic / Likely Pathogenic· 45 VUS of 79 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.70LOEUF
pLI 0.000
Z-score 0.12
OE 0.95 (0.541.70)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.36Z-score
OE missense 0.92 (0.801.06)
138 obs / 150.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.95 (0.541.70)
00.351.4
Missense OE0.92 (0.801.06)
00.61.4
Synonymous OE0.80
01.21.6
LoF obs/exp: 7 / 7.3Missense obs/exp: 138 / 150.3Syn Z: 1.19
DN
0.7228th %ile
GOF
0.77top 25%
LOF
0.3068th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

79 submitted variants in ClinVar

Classification Summary

Pathogenic23
Likely Pathogenic2
VUS45
Likely Benign3
23
Pathogenic
2
Likely Pathogenic
45
VUS
3
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
23
0
23
Likely Pathogenic
0
0
2
0
2
VUS
0
37
8
0
45
Likely Benign
0
3
0
0
3
Benign
0
0
0
0
0
Total04033073

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CMTM2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →